Oxidative metabolism of human platelets

Biochem Int. 1991 Nov;25(4):647-55.

Abstract

The reducing capacity toward cytochrome c present in human resting platelets increases upon platelet stimulation, and is partially inhibited by superoxide dismutase. This activity therefore represents the generation of superoxide anion. In order to evaluate hydrogen peroxide formation a quantitative assay by mean of dichlorofluorescin (DCFH) has been set up. The DCFH, trapped inside the cell, is oxidized by hydrogen peroxide to the fluorescent compound DCF. Basal DCF increases during activation of platelets by agonists. Arachidonic acid, calcium ionophore A23187 and to a lesser extent PMA and thrombin are the most effective. N-ethylmaleimide induces a dose-dependent DCFH oxidation and potentiates the effect of agonists. NAD(P)H--cytochrome c reductase enzyme, which catalyzes superoxide anion production, is present in platelets at high specific activity, as well as those enzymes who protect the cells from oxygen reactive species.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Platelets / drug effects
  • Blood Platelets / metabolism*
  • Cytochrome c Group / blood
  • Ethylmaleimide / pharmacology
  • Fluoresceins
  • Humans
  • Hydrogen Peroxide / blood
  • In Vitro Techniques
  • NADH, NADPH Oxidoreductases / blood
  • NADPH Oxidases
  • Oxidation-Reduction
  • Platelet Activation
  • Superoxides / blood

Substances

  • Cytochrome c Group
  • Fluoresceins
  • Superoxides
  • 2',7'-dichlorofluorescein
  • Hydrogen Peroxide
  • NADH, NADPH Oxidoreductases
  • NADPH Oxidases
  • Ethylmaleimide